Message from the Managing Director’s Desk
At Novum Pharmaceutical Research Services, our dedicated focus revolves around providing comprehensive end-to-end clinical research services to the global innovator, biotech, and generic pharmaceutical industries. We consistently set new standards in the clinical research sector, achieving milestones through both organic growth and strategic acquisitions.
In 2019, Lambda Therapeutic Research strategically expanded its North American presence by acquiring Novum Pharmaceutical Research Services, a distinguished 50-year-old CRO. This strategic move, following the integration of Biovail’s R&D facilities in Canada in 2010, marked Lambda’s second significant acquisition in North America. Operating under the unified brand of Novum Pharmaceutical Research Services in North America, Lambda reinforces its position as a key player in the global CRO market.
Read MoreMessage from the Managing Director’s Desk
At Novum Pharmaceutical Research Services, our dedicated focus revolves around providing comprehensive end-to-end clinical research services to the global innovator, biotech, and generic pharmaceutical industries. We consistently set new standards in the clinical research sector, achieving milestones through both organic growth and strategic acquisitions.
In 2019, Lambda Therapeutic Research strategically expanded its North American presence by acquiring Novum Pharmaceutical Research Services, a distinguished 50-year-old CRO. This strategic move, following the integration of Biovail’s R&D facilities in Canada in 2010, marked Lambda’s second significant acquisition in North America. Operating under the unified brand of Novum Pharmaceutical Research Services in North America, Lambda reinforces its position as a key player in the global CRO market.
Leveraging the trusted Novum brand, we are committed to delivering a seamless and enhanced suite of services across our North American operations. Over the past years, we have upheld an impeccable regulatory track record, successfully navigating various international inspections across our global units. We have also bolstered our clinical trial management capabilities by investing in top-tier scientific talent and expanding our global network of clinical sites. Our dedication to exceeding client expectations is unwavering, as we continue to offer a comprehensive portfolio of early and late-phase services.
With a focus on integrity, innovation, and client satisfaction, we are confident that our efforts will continue to meet and surpass client expectations, always
Bindi Chudgar
Managing Director
Services
Turnkey Clinical Trial Management solution for YOUR drug development programs
Careers
Novum prides itself on its talented and dedicated team of employees. The Novum team is passionate about customer satisfaction, safety and study integrity. All Novum clinical staff members receive extensive training designed to continually hone and increase the skills of each employee.
Want to participate in a study?
Last year we paid over $6.6 million to participants of our research studies.